{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-26-000106","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2026-09-28T20:01:31+00:00","discovered_at":"2026-09-28T20:04:56.128546+00:00","generated_at":"2026-10-12T13:34:38.969624+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Gossamer Bio regains Nasdaq minimum bid price compliance after 1-for-80 reverse split","bullets":["Gossamer Bio received a Sept. 25, 2026 Nasdaq letter stating it regained compliance with Nasdaq Listing Rule 5450(a)(1) minimum bid price requirement.","Nasdaq's April 8, 2026 letter had flagged noncompliance because GOSS common stock traded below $1.00 for 30 consecutive business days.","Gossamer effected a 1-for-80 reverse stock split on Sept. 10, 2026, and GOSS began trading split-adjusted on Nasdaq on Sept. 11, 2026.","The Nasdaq minimum bid price matter is now closed, according to the Sept. 25, 2026 letter."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-26-000106","json":"https://secwatch.observer/filing/0001728117-26-000106.json","markdown":"https://secwatch.observer/filing/0001728117-26-000106.md","text":"https://secwatch.observer/filing/0001728117-26-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000106/0001728117-26-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000106/goss-20260925.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:34:38.969624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}